Literature DB >> 6981179

Studies of artificial cryoprecipitates containing anti-DNA antibody activity.

R P Taylor, S J Waller, J S Davis, J B Winfield, K W Morley, E L Wright.   

Abstract

Artificial cryoprecipitates have been prepared from SLE sera by incubation of anti-double stranded DNA with 3H-PM2 DNA. IgM rheumatoid factor, and complement to study further the relationships between natural cryoprecipitation and the DNA/anti-DNA system in this disorder. Addition of rheumatoid factor and/or complement to a mixture of SLE serum and 3H-DNA results in increased precipitation of the 3H-DNA following incubation at 4 degrees C. Precipitation formed with added complement or complement plus rheumatoid factor could be rapidly resolubilized or reprecipitated by warming to 37 degrees C or recooling to 4 degrees C, i.e., exhibited the behavior of natural cryoprecipitates. The resolubilized cryoprecipitates contained excess antibody, because they bound significant quantities of additional 3H-DNA in the Farr assay. Of special interest was the observation that DNA binding activity frequently could be recovered from solubilized cryoprecipitates even though 3H-DNA was not added during the original cryoprecipitate preparation. With certain cryoprecipitations prepared in this way, the DNA binding activity was further increased by deoxyribonuclease treatment, raising the possibility that endogenous DNA may be constituent of such cryoprecipitates. The implications of these findings with respect to the nature of antibody-DNA immune complexes in SLE are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6981179     DOI: 10.1007/BF00541215

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  Systemic lupus erythematosus. Cryoprecipitation of sera.

Authors:  C L CHRISTIAN; W B HATFIELD; P H CHASE
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

2.  Interaction of human Clq with insoluble immunoglobulin aggregates.

Authors:  T Y Lin; D S Fletcher
Journal:  Immunochemistry       Date:  1978-02

3.  Cold-insoluble complexes and complement levels in systemic lupus erythematosus.

Authors:  P Stastny; M Ziff
Journal:  N Engl J Med       Date:  1969-06-19       Impact factor: 91.245

4.  Detection and characterization of DNA-anti-DNA complexes in a patient with systemic lupus erythematosus.

Authors:  C D Bruneau; J P Edmonds; G R Hughes; L Aarden
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

5.  A simple numerical method for the construction of isokinetic sucrose density gradients, and their application to the characterisation of immunoglobulin complexes.

Authors:  P Johns; D R Stanworth
Journal:  J Immunol Methods       Date:  1976-03       Impact factor: 2.303

6.  Interaction between rheumatoid factor and antibody/DNA complexes: enhancement of complement fixation.

Authors:  D A Birchmore; R P Taylor; S J Waller; J S Davis; K W Morley
Journal:  Arthritis Rheum       Date:  1981-03

7.  The specificity and polyvalency of binding of a monoclonal rheumatoid factor.

Authors:  R Eisenberg
Journal:  Immunochemistry       Date:  1976-04

8.  Studies of cryoproteins in systemic lupus erythematosus.

Authors:  L B Hanauer; C L Christian
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

9.  Failure to detect circulating DNA--anti-DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus.

Authors:  S Izui; P H Lambert; P A Miescher
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

10.  C1q PRECIPITINS IN THE SERA OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER HYPOCOMPLEMENTEMIC STATES: CHARACTERIZATION OF HIGH AND LOW MOLECULAR WEIGHT TYPES.

Authors:  V Agnello; D Koffler; J W Eisenberg; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.